These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND LDH AND Treatment
405 results:

  • 1. N-Phenyl ureidobenzenesulfonates, a novel class of human dihydroorotate dehydrogenase inhibitors inducing differentiation and apoptosis in acute myeloid leukemia cells.
    Bouzriba C; Chavez Alvarez AC; Ouellette V; Gagné-Boulet M; Hamel-Côté G; Bastien D; Laverdière I; Fortin S
    Biomed Pharmacother; 2024 Dec; 181():117717. PubMed ID: 39637752
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. n-3 polyunsaturated fatty acids enhanced efficacy of cytarabine in iron-overloaded NALM-6 cells via apoptotic and oxidative pathways.
    Bahraini F; Sayadi M; Safarpour H; Zarban A; Mesbahzadeh B; Sajjadi SM
    Toxicol In Vitro; 2025 Mar; 103():105976. PubMed ID: 39613235
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring the Prevalence and Prognostic Impact of Wilms Tumor 1 Exon 7 Mutation Status with Combinations of FLT3-ITD and NPM1 Mutations as Potential Molecular Biomarkers in Acute Myeloid leukemia Patients with Normal Cytogenetics.
    John Anitha GR; Radhakrishnan Chandraprabha V; Padmakumar D; Mohanan Sreelatha M; Padmakumar A; Gopinath P; Thampirajan Vimala Devi AR; Lathika Surendran S; Narayanan G; Sreedharan H; Mohanan Nair JKK
    Asian Pac J Cancer Prev; 2024 Oct; 25(10):3463-3470. PubMed ID: 39471012
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Determination of Serum Myeloperoxidase (MPO) and lactate dehydrogenase (ldh) as a tumour Marker in Chronic Myeloid Leukaemia (CML).
    Wahhab Ali KA; Ahmed AA; Mohammed ST
    J Pak Med Assoc; 2024 Oct; 74(10 (Supple-8)):S283-S286. PubMed ID: 39434323
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.
    de Groot FA; Dekker TJA; Doorduijn JK; Böhringer S; Brink M; de Groen RAL; de Haan LM; Woei-A-Jin FJSH; Noordenbos T; Sijs-Szabo A; Oudshoorn MA; Lam KH; Diepstra A; Te Boome LCJ; Terpstra V; Bohmer LH; Nicolae A; Posthuma EFM; Koens L; Durian MF; Stavast J; van der Poel MWM; Hamid MA; Stevens WBC; van Rooij SLM; Oostvogels RS; Mühlebner A; Neelis KJ; van den Brand M; Tousseyn T; Dierickx D; de Weerdt O; Beeker A; Jansen PM; Kersten MJ; Zijlstra JM; Chamuleau MED; Veelken H; Bromberg JCE; Nijland M; Vermaat JSP
    Eur J Cancer; 2024 Dec; 213():115068. PubMed ID: 39427440
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Intragenic antimicrobial peptide Hs02 toxicity against leukemia cell lines is associated with increased expression of select pyroptotic components.
    Mota IS; Cardoso M; Bueno J; da Silva IGM; Gonçalves J; Bao SN; Neto BAD; Brand G; Corrêa JR; Leite JRSA; Saldanha-Araujo F
    Toxicol In Vitro; 2024 Dec; 101():105945. PubMed ID: 39343072
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Aberrant Expression of Small Nucleolar RNA
    Liu YQ; Chen SP; Yin Y; Shen JZ; Zeng MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):979-986. PubMed ID: 39192386
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group.
    Katodritou E; Dalampira D; Delimpasi S; Ntanasis-Stathopoulos I; Karaolidou F; Gkioka AI; Labropoulou V; Spanoudakis E; Triantafyllou T; Kotsopoulou M; Michalis E; Vadikolia C; Papadopoulou T; Sevastoudi A; Michael M; Daiou A; Pentidou A; Kostopoulos I; Palaska V; Gavriatopoulou M; Kyrtsonis MC; Verrou E; Kastritis E; Dimopoulos MA; Terpos E
    Am J Hematol; 2024 Oct; 99(10):1897-1905. PubMed ID: 38953456
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Triple-Negative Myelofibrosis: Disease Features, Response to treatment and Outcomes.
    Aguirre LE; Jain A; Ball S; Ali NA; Volpe VO; Tinsley-Vance S; Sallman D; Sweet K; Lancet J; Padron E; Yun S; Kuykendall A; Komrokji R
    Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):459-467. PubMed ID: 38548563
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic leukemia/Lymphoma from Multicenter].
    Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
    Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia].
    Dou XL; Liu RX; Liu Y; Peng N; Wen L; Wu Y; Li Q; Zhong YP; Zhou X; Liao AJ; Jiang HN; Ma XJ; Dong HH; Fan SJ; Zhao YQ; Hu DH; Lu J
    Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):499-506. PubMed ID: 38317361
    [No Abstract]    [Full Text] [Related]  

  • 14. "Combination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells".
    Golestani A; Rahimi A; Najafzadeh M; Sayadi M; Sajjadi SM
    Mol Biol Rep; 2024 Jan; 51(1):108. PubMed ID: 38227060
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.
    Didi I; Alliot JM; Dumas PY; Vergez F; Tavitian S; Largeaud L; Bidet A; Rieu JB; Luquet I; Lechevalier N; Delabesse E; Sarry A; De Grande AC; Bérard E; Pigneux A; Récher C; Simoncini D; Bertoli S
    Leuk Res; 2024 Jan; 136():107437. PubMed ID: 38215555
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
    Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
    Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Metformin mitigates doxorubicin-induced cardiotoxicity
    Wei J; Yang Q; Lin L; Zhu C; Wei J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1682-1688. PubMed ID: 37933643
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Richter transformation - retrospective treatment outcomes analysis in Polish Adult leukemia Study Group.
    Sośnia O; Pruszczyk K; Danecki M; Wąsik-Szczepanek E; Tryc-Szponder J; Iskierka-Jażdżewska E; Majeranowski A; Krzemień H; Bołkun Ł; Paszkiewicz-Kozik E; Drozd-Sokołowska J; Kwiatkowski J; Wiśniewska-Organek D; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Budziszewska B; Jamroziak K; Hus I; Lech-Marańda E; Puła B
    Leuk Lymphoma; 2024 Feb; 65(2):175-186. PubMed ID: 37921067
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
    Fattizzo B; Gurnari C; Cassanello G; Bortolotti M; Awada H; Giammarco S; Consonni D; Sica S; Gandhi S; Trikha R; Large J; Salter S; Maciejewski JP; Barcellini W; Kulasekararaj AG
    Leukemia; 2023 Dec; 37(12):2479-2485. PubMed ID: 37794100
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
    Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
    PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 21.